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Commentary 
Mitochondrial DNA (mtDNA) research is emerging within the dermatological field as a unique 
biomarker for diagnostic, prognostic and even therapeutic exploration. Since the first review of the 
role of mtDNA in skin disease was authored by our group some 14 years ago (1), there have been 
many exciting observations linking mitochondria to the defective structural, cell signaling, and 
oxidative damage pathways that promote skin disease manifestation.  Feichtinger et al (2) have 
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compiled an extensive and interesting review of recent literature that examines the relationship 
between known molecular paradigms of skin disease and intrinsic mitochondrial health. Whilst it is 
unrealistic for the authors to fully explore all recent advances within normal journal constraints, 
there are some surprising omissions, including our own detailed review of mtDNA and skin disease 
in 2000.  Feichtinger et al (2) highlight the breadth of potential mitochondrial involvement in 
conditions not traditionally associated with metabolic or oxidative phosphorylation defects. On 
consideration however, it seems intuitive that any global defect of cell function is capable of 
exerting detrimental secondary effects on mitochondrial function. An example of this is mutation of 
the keratin 5 and 14 genes which are associated with the dermatological manifestation (e.g. skin 
blistering) of epidermolysis bullosa simplex. The altered mitochondrial network formation 
highlighted by Feichtinger et al (2), is likely to be a secondary factor in disease causation. 
Nonetheless, such mitochondrial aspects warrant investigation as potential therapeutic and 
prognostic markers within the context of wider disease state etiologies. 
 
Mitochondria are the major site of ATP generation within cells. 5 enzyme complexes are involved in 
the generation of the energy currency molecule ATP. Complexes I-IV form the mitochondrial 
electron transport chain (mETC), whose primary function is the generation and maintenance of an 
electromotive proton gradient across the inner mitochondrial membrane as summarized in figure 1. 
Succinate deyhydrogenase (Complex II) forms an important ‘metabolic bridge’ by performing a duel 
role as both a proximal mETC component and as an element of the tricarboxylic acid (TCA) cycle. It 
is known that several mtDNA mutations affecting genes encoding mETC components are complicit 
in defective mitochondrial function (recently reviewed in (3)). 
 
Cells contain many copies of the mitochondrial genome, and as such may contain a ratio of mutant 
or damaged mtDNA to wildtype or undamaged mtDNA (termed ‘heteroplasmy’). The threshold of 
tolerable accumulated damage can be breached over time, ultimately leading to the disease state 
manifestation (reviewed in (4)). Feichtinger et al (2) present several skin diseases involving mtDNA 
mutations; however discussion regarding the important effects of heteroplasmy with regard to 
disease development is missing possibly due to space constraints. Heteroplasmic effects are of 
critical importance, as mtDNA mutations may not be significant to cause a disease when present at 
only low levels within a cell (4)). The occurrence of heteroplasmy within the mitochondria allows 
damage to accumulate to a point without affecting mitochondrial function. This, along with limited 
repair mechanisms and lack of histone body association, permits the use of mtDNA as a reliable 
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biomarker for damage accumulation in both human and animal skin (4,6,S1). Mutation in a nuclear 
or mitochondrial gene encoding an mETC subunit causes mitochondrial dysfunction, however 
impaired mtDNA maintenance, defects in mitochondrial translation factors, and other indirect 
mechanisms can also manifest disease states (reviewed in (S2)). In 2013, mitochondria-targeted 
transcription activator-like effector nucleases (mitoTALENs) were first demonstrated that cleave 
different classes of pathogenic mtDNA in dermal fibroblast cybrids (S3). Such mitoTALEN 
technology may present a novel therapeutic tool for targeting skin manifestations of mitochondrial 
disease. 
 
Constant exposure to solar radiation, chemical and mechanical stresses places unique repair and 
protection pressures upon the skin compared to other organs. The damaging effects of UV 
irradiation upon mitochondrial damage and function in skin have been the subject of intensive 
recent investigation (S1, 4, S4). From our pioneering observation reported at the ESDR in 1996, the 
importance of using mtDNA as a reliable and sensitive biomarker of sun-exposure has been 
successfully exploited by our group and many others within dermatological areas including aging 
and cancer (reviewed in (S5, 6)). In addition, oxidative stress-induced mtDNA damage in skin cells 
has recently been used as a tool for assessing the potency of cell and mitochondria-targeted anti-
oxidants (7) and has potential for screening therapeutic compounds including anti-oxidants used in 
cosmetics and the diet.  This is alluded to by Feichtinger et al (2) who highlight nicotinamide 
(vitamin B3) a compound which, as a precursor of nicotinamide adenine dinucleotide within 
mitochondrial energy metabolism, has provided benefit by reducing actinic keratosis (S6) and 
mitochondrial myopathy (S7).  Feichtinger et al (2) also briefly mention the therapeutic targeting of 
mitochondria in skin disease using the drug dithranol as a treatment for psoriasis. The mechanism 
of action was described as ‘damaging’ to mitochondria via the uncoupling of ATP production (2,S8). 
More recently, dithranol’s mechanism of action has been elucidated (S9). The drug interacts 
specifically with the mitochondrial ubiquinone pool in keratinocyte cells subsequently inducing 
apoptosis by mitochondrial membrane potential disruption, causing a release in cytochrome c. This 
action is dependent upon the presence of a functional mETC (S9). 
 
In the respect of a functional mETC, Feichtinger et al (2) have highlighted the important potential 
roles of individual mETC complexes in various skin diseases however Complex II was not explored. 
This often over-looked complex was recently implicated in the ageing process of both human (S10) 
and mouse skin (S11). It was also reported to produce reactive oxygen species (ROS) to a similar 
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extent as Complexes I and III (8,S12,S13). The authors concluded that complex II may be more 
important than previously thought. Mutant Complex II subunits have been shown to increase ROS 
generation (S14-17), while Complex II ROS flux has also been shown to prevent cell cycle progress, 
inferring association with senescence induction (S18). Complex II’s unique ‘metabolic hinge’ role in 
both the TCA cycle and the mETC dictates that the importance of this Complex is not to be 
underestimated. Further elucidation of Complex II’s impact will provide a more complete picture of 
mitochondrial involvement in skin disease. 
 
Without doubt, alterations in mitochondrial status and function impact skin health, although it is 
difficult to elucidate the individual contributions of UV irradiation, chemical insult, injury and 
genetic predisposition over a lifetime of stress and strain. Technological developments regarding 
real-time methods of ROS formation monitoring and miniaturized tools for mitochondrial analysis 
are pushing the boundaries of novel mitochondrial investigations and insight (S19,9). It is important 
that the momentum of skin-directed mitochondrial research is maintained; pioneering the research 
of biomarkers, etiologies and potential therapeutic strategies for the cure and prevention of such 
highly visible and life limiting diseases.   
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Figures 
 
Figure 1: Oxidative phosphorylation is performed by 5 enzyme Complexes located on the inner 
mitochondrial membrane.  A proton motive gradient is maintained by Complexes I, III and IV 
pumping protons from the inner mitochondrial matrix into the intermembrane space. Electrons 
entry to the mETC from FADH is mediated by Complex II. The phosphorylation of ADP to ATP is 
performed by terminal enzyme Complex ATP synthase (Complex V) by coupling the reaction to the 
passive translocation of protons down the sustained gradient. With the exception of Complex II, the 
subunits comprising each Complex are encoded both by nuclear and mitochondrial genes; Complex 
II genes are encoded solely by the nuclear genome.  
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